Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Russo

Thoracic Surgery (Cardiothoracic Vascular Surgery) New Brunswick, NJ Medical Doctor

NPI 1326289786 CMS profile 242215

1 Robert Wood Johnson Pl, New Brunswick, NJ 08901

Open in the dashboard

General payments

$219,091

675 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,207,985 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Mark Russo of New Brunswick, NJ is reported in the CMS Open Payments database as having received $219,091 across 675 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,207,985 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $32,108 102
2024 General $25,310 82
2023 General $26,290 67
2022 General $10,651 64
2021 General $28,902 97
2020 General $39,872 71
2019 General $55,959 192

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Russo
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Mark Russo were reported at $32,108. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Mark Russo Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $55,959 $886 $178–$3,167 $163
2020 $39,872 $341 $108–$1,605 $114
2021 $28,902 $453 $125–$1,886 $132
2022 $10,651 $695 $180–$2,566 $149
2023 $26,290 $745 $205–$2,662 $160
2024 $25,310 $799 $214–$2,967 $164
2025 $32,108 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $108,120 301 payments
  2. Abbott Laboratories $102,189 264 payments
  3. Boston Scientific Corporation $2,074 16 payments
  4. Siemens Medical Solutions USA, Inc. $2,000 1 payment
  5. Abiomed $1,801 43 payments
  6. Atricure, Inc. $934 31 payments
  7. Opsens Inc. $500 1 payment
  8. Dilon Technologies, Inc. $334 2 payments
  9. Medtronic, Inc. $327 3 payments
  10. Ancora Heart, Inc. $206 1 payment
  11. Other $607 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $95,205 33 payments
  2. Travel and Lodging $50,757 90 payments
  3. Food and Beverage $33,249 537 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,388 4 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $9,640 3 payments
  6. Honoraria $9,500 4 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $9,020 1 payment
  8. Long term medical supply or device loan $282 1 payment
  9. Education $51 2 payments
Products named General payments · program years 2019–2025
  1. Trifecta GT Tissue Heart Valve $31,344 40 payments
  2. Edwards SAPIEN 3 Transcatheter Heart Valve $24,769 58 payments
  3. MitraClip System $19,448 22 payments
  4. Mitra Clip system $15,248 13 payments
  5. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $9,135 9 payments
  6. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $6,967 25 payments
  7. NAVITOR Vascular $6,919 19 payments
  8. NAVITOR Structural Heart $6,607 18 payments
  9. EPIC $5,471 54 payments
  10. PORTICO $4,950 16 payments
  11. Other $31,411 277 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$238,578

Medicare's payments for the services billed

Medicare patients

298

Average age 80

Services billed

540

132 women, 166 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Atrial fibrillation 54%
Arthritis 52%
Diabetes 46%
Chronic kidney disease 45%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

675 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record